Mayers's most recent trade in Citius Oncology Inc. was a trade of 21,228 Common Stock done . Disclosure was reported to the exchange on July 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Citius Oncology Inc. | Joel D. Mayersohn | Director | Other type of transaction at price $ 0.00 per share. | 28 Jul 2025 | 21,228 | 21,228 | - | 0 | Common Stock | |
| Citius Oncology Inc. | Joel D. Mayersohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) |